Ensuring Patient Access to Critical Breakthrough Products Act
Bill journey · stage 1 of 5
Just introduced
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedSep 17, 2025
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Who’s behind it
- Introduced in HouseSep 15, 2025
- Sep 17, 2025Committee
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
- Sep 17, 2025Committee
Committee Consideration and Mark-up Session Held
- Sep 15, 2025IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sep 15, 2025IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sep 15, 2025IntroReferralIntro-H
Introduced in House
- Sep 15, 2025IntroReferral1000
Introduced in House